BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19700754)

  • 21. Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.
    Hillen MR; Kruize AA; Bikker A; Wenting-van Wijk M; Radstake TR; Hack CE; Lafeber FP; van Roon JA
    Mod Rheumatol; 2016; 26(1):105-9. PubMed ID: 25995032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.
    Ciccia F; Guggino G; Rizzo A; Bombardieri M; Raimondo S; Carubbi F; Cannizzaro A; Sireci G; Dieli F; Campisi G; Giacomelli R; Cipriani P; De Leo G; Alessandro R; Triolo G
    Clin Exp Immunol; 2015 Aug; 181(2):219-29. PubMed ID: 25880879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
    Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
    Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.
    Ciccia F; Guggino G; Rizzo A; Alessandro R; Carubbi F; Giardina A; Cipriani P; Ferrante A; Cannizzaro A; Giacomelli R; Triolo G
    Rheumatology (Oxford); 2014 Jul; 53(7):1313-20. PubMed ID: 24602921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
    Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
    Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
    Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
    J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.
    Ciccia F; Alessandro R; Rodolico V; Guggino G; Raimondo S; Guarnotta C; Giardina A; Sireci G; Campisi G; De Leo G; Triolo G
    Rheumatology (Oxford); 2013 Jun; 52(6):1009-17. PubMed ID: 23392590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.
    Sakai A; Sugawara Y; Kuroishi T; Sasano T; Sugawara S
    J Immunol; 2008 Aug; 181(4):2898-906. PubMed ID: 18684981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome.
    Sarigul M; Yazisiz V; Bassorgun CI; Ulker M; Avci AB; Erbasan F; Gelen T; Gorczynski RM; Terzioglu E
    Lupus; 2010 Feb; 19(2):138-45. PubMed ID: 19952070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
    Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
    Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
    Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
    Fox RI; Kang HI; Ando D; Abrams J; Pisa E
    J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.
    Alunno A; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Di Benedetto P; Cipriani P; Giacomelli R; Gerli R
    Clin Exp Immunol; 2016 Jun; 184(3):284-92. PubMed ID: 26814615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
    Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
    Kim D; Kim JY; Jun HS
    Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.
    Hu P; Cai J; Yang C; Xu L; Ma S; Song H; Yang P
    Int Immunopharmacol; 2024 Jan; 126():111282. PubMed ID: 38061117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Rizzo C; Mohammadnezhad L; Lo Pizzo M; Lentini VL; Di Liberto D; La Barbera L; Raimondo S; Shekarkar Azgomi M; Urzì O; Berardicurti O; Campisi G; Alessandro R; Giacomelli R; Dieli F; Ciccia F
    RMD Open; 2023 May; 9(2):. PubMed ID: 37137540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients.
    Sthoeger Z; Sharabi A; Asher I; Zinger H; Segal R; Shearer G; Elkayam O; Mozes E
    Clin Immunol; 2018 Jul; 192():85-91. PubMed ID: 29730433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.
    Li X; Li X; Qian L; Wang G; Zhang H; Wang X; Chen K; Zhai Z; Li Q; Wang Y; Harris DC
    J Rheumatol; 2007 Dec; 34(12):2438-45. PubMed ID: 18050367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.